Attached files
| file | filename |
|---|---|
| 10-Q - UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING - UTAH MEDICAL PRODUCTS INC | utmd-20200930.htm |
| EX-32.1 - EXHIBIT 32.1 - UTAH MEDICAL PRODUCTS INC | utmd_ex32z1.htm |
| EX-31.2 - EXHIBIT 31.2 - UTAH MEDICAL PRODUCTS INC | utmd_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 - UTAH MEDICAL PRODUCTS INC | utmd_ex31z1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Utah Medical Products, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian L. Koopman, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/ Brian L. Koopman
Brian L. Koopman
Principal Financial Officer
November 6, 2020
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.